Inmune Bio(DE:0Y2)
€1.390.00 (0.00%)
DE:0Y2
Inmune Bio earnings date
€1.39
At close:0.00 (0.00%)
Inmune Bio (0Y2) Q2 2022 Earnings Report
0 Followers
DE:0Y2 Q2 2022 EPS Results
- Actual EPS
- -EUR 0.34
- Consensus EPS
- -EUR 0.44
- Beat/Miss
- Beat by +EUR 0.09
- One Year Ago EPS
- -EUR 0.39
DE:0Y2 Q2 2022 Revenue Results
- Actual Revenue
- EUR 14.33K
- Expected Revenue
- EUR 0
- Beat/Miss
- Beat by +EUR 14.33K
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/03/2022
- Time
- After Close
- Conference Call
- Wednesday, August 3, 2022
DE:0Y2 Upcoming Earnings
Inmune Bio's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:0Y2 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | -0.19- | -0.18 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.13-0.15 | -0.21 | 29.17% (+0.06) | |
| Aug 06, 2026 | 2026 (Q2) | -0.19-0.04 | -0.94 | 95.24% (+0.90) | |
| May 07, 2026 | 2026 (Q1) | -0.22-0.18 | -0.39 | 53.49% (+0.21) | |
| Mar 30, 2026 | 2025 (Q4) | -0.24-0.18 | -0.36 | 50.50% (+0.18) | |
| Oct 30, 2025 | 2025 (Q3) | -0.28-0.21 | -0.54 | 60.00% (+0.32) | |
| Aug 07, 2025 | 2025 (Q2) | -0.34-0.94 | -0.45 | -110.00% (-0.49) | |
| May 08, 2025 | 2025 (Q1) | -0.42-0.39 | -0.55 | 29.51% (+0.16) | |
| Mar 27, 2025 | 2024 (Q4) | -0.49-0.36 | -0.42 | 14.89% (+0.06) | |
| Oct 31, 2024 | 2024 (Q3) | -0.45-0.54 | -0.43 | -25.00% (-0.11) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
